Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 57 resultados

PITT-Inflame: Platelet-derived Integrin- and Tetraspanin-enriched Tethers as key effectors in thrombo-Inflammation UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT tramitó un HORIZON EUROPE: ERC-2023-ADG Platelets are mediators of haemostasis and thrombosis, but also increasingly recognized as versatile effector cells of innate immunity. The...
2024-10-01 - 2029-09-30 | Financiado

PITT-Inflame: Platelet derived Integrin and Tetraspanin enriched Tethers as key effectors in thrombo Inflammation UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT tramitó un HORIZON EUROPE: ERC-2023-ADG Platelets are mediators of haemostasis and thrombosis, but also increasingly recognized as versatile effector cells of innate immunity. The...
2024-06-26 - 2029-09-30 | Financiado

Vasc-on-Demand: Prefabricated Mature Blood Vessels and Tools for Vascularized 3D Cell Culture UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT tramitó un HORIZON EUROPE: HORIZON-EIC-2023-TRANSITION-01 In 2020, the cell culture market was valued at $19 billion USD, with consumables comprising more than 60% of the market. The emerging 3D cel...
2024-05-01 - 2027-04-30 | Financiado

IMPROVA: e Intervention Enhancing Mental Health in Adolescents UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT participó en un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-two-stage The e-Intervention Enhancing Mental Health in Adolescents project, IMPROVA, will co-design, pilot, evaluate, and facilitate the upscaling of...
2023-03-17 - 2027-03-31 | Financiado

Aqua-Synapse: The health benefits of deuterium depletion on synaptic function, regional metabolism, and behaviour UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT participó en un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01 Core idea of this project is to establish the mechanistic basis for the positive health effects of deuterium depleted water and determine wh...
2022-09-27 - 2026-12-31 | Financiado

OralNiche: Dissecting the impact of epithelial stem cell niches on oral cancer heterogeneity UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT tramitó un HORIZON EUROPE: ERC-2021-STG The oral epithelium is a unique tissue with a high degree of structural heterogeneity and distinct microenvironments (niches). However, the...
2022-06-01 - 2027-05-31 | Financiado

COVend: Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stag... UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT participó en un HORIZON EUROPE: HORIZON-HLTH-2021-CORONA-01 More than 2.7 million hospitalisations of COVID-19-infected patients have occurred in Europe alone since the outbreak of the coronavirus in...
2021-11-12 - 2025-01-31 | Financiado

CEN: Cerebellum and Emotional Networks UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT participó en un H2020: H2020-MSCA-ITN-2020 This Innovative Training Network (ITN) brings together leading European research labs for the interdisciplinary study of cerebellar contribu...
2021-04-30 - 2025-05-31 | Financiado

AIDPATH: Artificial Intelligence driven Decentralized Production for Advanced Therapies in the Hospital UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT participó en un H2020: H2020-DT-2018-2020 AIDPATH (Artificial Intelligence-driven, Decentralized Production for Advanced Thera-pies in the Hospital) is a high-energy EU consortium, d...
2020-12-07 - 2024-12-31 | Financiado

T2EVOLVE: Accelerating Development and Improving Access to CAR and TCR engineered T cell therapy UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT tramitó un H2020: H2020-JTI-IMI2-2019-18-two-stage Immune cells that are empowered by gene-engineering to seek and destroy cancer cells (engineered T cell therapy) constitute a transformative...
2020-11-24 - 2025-12-31 | Financiado

DeMANS: Design and manufacture of sustainable materials for additive manufacturing technologies UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT participó en un H2020: H2020-MSCA-RISE-2020 There is an urgent need to reduce reliance on fossil fuel derived plastics. The vast majority of these polymers cannot be recycled due to ad...
2020-11-17 - 2026-04-30 | Financiado

SEROTONIN and BEYOND: Serotonin and BEYOND Brain development research Excelling Young Ones in Neurotechnologies and Disco... UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT participó en un H2020: H2020-MSCA-ITN-2020 Serotonin is a neurotransmitter playing a crucial in the onset and treatment of neuropsychiatric disorders. Most of the drugs currently used...
2020-08-28 - 2024-12-31 | Financiado

Design2Flow: Disposable well plate inserts and perfusion chambers for easy to use and generic microchannel creati... UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT tramitó un H2020: ERC-2019-PoC Functional 3D tissue models could replace animal experiments and significantly reduce the cost of over 100 million € that pharmaceutical com...
2020-02-10 - 2021-12-31 | Financiado

PharmaLedger: PharmaLedger UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage The PharmaLedger project will create a blockchain-based framework for the efficient digitization of the healthcare industry. The goal of the...
2019-12-16 - 2022-12-31 | Financiado

BRAV3: Computational biomechanics and bioengineering 3D printing to develop a personalized regenerative bio... UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT participó en un H2020: H2020-SC1-BHC-2018-2020 Ischemic heart disease is the main cause of death in the EU, straining patients and economies. Regenerative Medicine has failed at deliverin...
2019-12-06 - 2024-12-31 | Financiado

miniNO: Associative mechanisms linking a defective minipuberty to the appearance of mental and nonmental dis... UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT participó en un H2020: H2020-SC1-BHC-2018-2020 The miniNO project aims to identify the key causative mechanisms of the lifelong multimorbidity associated with preterm birth. Prematurity i...
2019-12-05 - 2025-12-31 | Financiado

UNITI: Unification of treatments and Interventions for Tinnitus patients UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT participó en un H2020: H2020-SC1-BHC-2018-2020 Tinnitus is the perception of a phantom sound and the patient’s reaction to it. Tinnitus remains a scientific and clinical enigma of iTinnit...
2019-11-24 - 2023-09-30 | Financiado

KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILI...